New hope for advanced cancer patients as experimental drug enters human testing.
NCT ID NCT06726369
First seen May 08, 2026 · Last updated Jun 17, 2026 · Updated 8 times
Summary
This early-stage study is testing an experimental drug called MK-6204 in about 90 adults with advanced solid tumors (such as colorectal, lung, or stomach cancer) that have not responded to standard therapies. The main goals are to check the drug's safety and find the right dose. Researchers will also look for early signs that the drug can shrink or control tumors. This is not a cure, but a step toward a possible new treatment option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Cancer Hospital
RECRUITINGBeijing, 100142, China
Contact
Contact
-
Chongqing University Cancer Hospital
NOT_YET_RECRUITINGChongqing, China
-
Fujian Provincial Cancer Hospital
NOT_YET_RECRUITINGFuzhou, China
-
Hubei Cancer Hospital
NOT_YET_RECRUITINGWuhan, China
-
Hunan Cancer Hospital
NOT_YET_RECRUITINGChangsha, 410031, China
-
Shanghai East Hospital
NOT_YET_RECRUITINGShanghai, China
-
West China Hospital of Sichuan University
NOT_YET_RECRUITINGChengdu, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.